Strategic Combinations: The Future of Oncolytic Virotherapy with Reovirus.
about
Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus.Oncolytic Reovirus Infection Is Facilitated by the Autophagic Machinery.Baculovirus-assisted Reovirus Infection in Monolayer and Spheroid Cultures of Glioma cells.Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas.Current understanding of reovirus oncolysis mechanisms.Oncolytic virus and PD-1/PD-L1 blockade combination therapy
P2860
Strategic Combinations: The Future of Oncolytic Virotherapy with Reovirus.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Strategic Combinations: The Future of Oncolytic Virotherapy with Reovirus.
@en
type
label
Strategic Combinations: The Future of Oncolytic Virotherapy with Reovirus.
@en
prefLabel
Strategic Combinations: The Future of Oncolytic Virotherapy with Reovirus.
@en
P2093
P1476
Strategic Combinations: The Future of Oncolytic Virotherapy with Reovirus.
@en
P2093
Cariad Chester
Holbrook E Kohrt
Narendiran Rajasekaran
P304
P356
10.1158/1535-7163.MCT-15-0695
P577
2016-04-14T00:00:00Z